Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis

Molecular Cancer

Volumn 8, Issue , 2009, Pages

  Nardinocchi, Lavinia ^a   Puca, Rosa ^a   Sacchi, Ada ^a   D'Orazi, Gabriella ^a,b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; COBALT CHLORIDE; DOXORUBICIN; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN P53; SMALL INTERFERING RNA; ANTINEOPLASTIC ANTIBIOTIC; CARRIER PROTEIN; HIF1A PROTEIN, HUMAN; HIPK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CATALYSIS; CELL ACTIVITY; CELL HYPOXIA; CELL SURVIVAL; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIZATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PROTEIN DEGRADATION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; DRUG EFFECT; DRUG RESISTANCE; GENETIC TRANSFECTION; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL HYPOXIA; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 61349121467     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-8-1     Document Type: Article

References (28)

1. Kim YH Choi CY Lee SJ Conti MA Kim Y Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors J Biol Chem 1998, 273:25875-25879. 10.1074/jbc.273.40.25875 9748262
2. D'Orazi G Cecchinelli B Bruno T Manni I Higashimoto Y Saito S Gostissa M Coen S Marchetti A Del Sal G Piaggio G Fanciulli M Appella E Soddu S Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis Nature Cell Biol 2002, 4:11-19. 10.1038/ncb714 11780126
3. Hofmann TG Moller A Sirma H Zebtgraft H Taya Y Droge W Will H Schmitz ML Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2 Nauret Cell Biol 2002, 4:1-10. 10.1038/ncb715
4. Puca R Nardinocchi L Gal H Rechavi G Amariglio N Domany E Notterman DA Scarsella M Leonetti C Sacchi A Blandino G Givol D D'Orazi G Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown Cancer Res 2008, 68:3707-3714. 10.1158/ 0008-5472.CAN-07-6776 18483253
5. Di Stefano V Rinaldo C Sacchi A Soddu S D'Orazi G Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis Exp Cell Res 2004, 293:311-320. 10.1016/j.yexcr.2003.09.032 14729469
6. Nardinocchi L Puca R Sacchi A D'Orazi G HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA Biochem Biophys Res Commun 2007, 361:249-255. 10.1016/j.bbrc.2007.07.031 17658469
7. Puca R Nardinocchi L Pistritto G D'Orazi G Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells Gynecol Oncol 2008, 109:403-410. 10.1016/j.ygyno.2008.02.018 18395248
8. D'Orazi G Sciulli MG Di Stefano V Riccioni S Frattini M Falcioni R Bertario L Sacchi A Patrignani P Homeodomain-interacting protein kinase-2 restrains cytosolic-phospholipase-A2-dependent prostaglandin-E2 generation in human colorectal cancer cells Clin Cancer Res 2006, 12:735-741. 10.1158/1078-0432.CCR-05-1557 16467083
9. Nardinocchi L Puca R Guidolin D Belloni AS Bossi G Michiels C Sacchi A Onisto M D'Orazi G Trancriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth BBA Mol Cell Res 2008. DOI:10.1016/j.bbamcr.2008.10.013.
10. Puca R Nardinocchi L D'Orazi G Regulation of vascular endothelial growth factor expression ny homeodomain-interacting protein kinase-2 J Exp Clin Cancer Res 2008, 27:22. 2494538 18644116 10.1186/1756-9966-27-22
11. Semenza GL Involvement of hypoxia-inducible factor 1 in human cancer Nature Rev Cancer 2003, 3:721-732. 10.1038/nrc1187
12. Wang GL Jiang B-H Rue EA Semenza GL Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension Proc Natl Acad Sci USA 1995, 92:5510-5514. 41725 7539918 10.1073/ pnas.92.12.5510
13. Jiang BH Semenza GL Bauer H Marti H Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension Am J Physiol 1996, 271:C1172-C1180. 8897823
14. Liu L Ning X Sun L Zhang H Shi Y Guo C Han S Liu J Sun S Han Z Wu K Fan D Hypoxia-inducible factor-1a contributes to hypoxia-induced chemoresistance in gastric cancer Cancer Sci 2008, 99:121-128. 17953712
15. Huang LE Arany Z Livingston DM Bunn HF Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit J Biol Chem 1996, 271:32253-32259. 10.1074/jbc.271.50.32253 8943284
16. Wang GL Semenza GL General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia Proc Natl Acad Sci USA 1993, 90:4304-4308. 46495 8387214 10.1073/pnas.90.9.4304
17. Raguz S Yague E Resistance to chemotherapy: New treatments and novel insights Br J Cancer 2008, 99:387-391. 10.1038/sj.bjc.6604510 18665178
18. Greijer AE Wall van der E The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis J Clin Pathol 2004, 57:1009-1014. 1770458 15452150 10.1136/jcp.2003.015032
19. Borst P Jankers J Rottenberg S What makes tumors multidrug resistant? Cell Cycle 2007, 22:2782-2787
20. Fardel O Lecureur V Guillouzo A The P-glicoprotein multidrug transporter Gen Pharmacol 1996, 27:1283-1291. 9304397
21. Comerford KM Wallace TJ Karhnausen J Louis NA Montalto MC Colgan SP Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene Cancer Res 2002, 62:3387-3394. 12067980
22. Talks KL Turley H Gatter KC Maxwell PH Pugh CW Ratcliff PJ Harris AL The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages Am J Pathol 2000, 157:411-421. 1850121 10934146
23. Zhang Q Yoshimatsu Y Hildebrabd J Frisch SM Goodman RH Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP Cell 2003, 115:177-186. 10.1016/ S0092-8674(03)00802-X 14567915
24. Hofmann TG Stollberg N Schmitz ML Will H HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells Cancer Res 2003, 63:8781-8787
25. Doxakis E Huang EJ Davies AM Homeodomain-interacting protein kinase-2 regulates apoptosis in developing sensory and sympathetic neurons Curr Biol 2004, 14:1761-1765. 10.1016/j.cub.2004.09.050 15458648
26. Unruh A Ressel A Mohamed HG Johnson RS Nadrowitz R Richter E Katschinski DM Wenger RH The hypoxia-inducible factor-1α is a negative factor for tumor therapy Oncogene 2003, 22:3213-3220. 10.1038/sj.onc.1206385 12761491
27. Chen P Iavarone A Fick J Edwards M Prados M Israel MA Constitutional p53 mutations associated with brain tumors in young adults Cancer Genetics and Cytogenetics 1995, 2:106-115. 10.1016/0165-4608(94)00213-U
28. Di Stefano V Mattiussi M Sacchi A D'Orazi G HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations FEBS Lett 2005, 579:5473-5480. 10.1016/j.febslet.2005.09.008 16212962